BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1292993)

  • 21. Cervical cancer screening program of Paraná: cost-effective model in a developing country.
    Bleggi Torres LF; Werner B; Totsugui J; Collaço LM; Araújo SR; Huçulak M; Boza EJ; Fischer RM; De Laat L; Sobbania LC; Raggio A
    Diagn Cytopathol; 2003 Jul; 29(1):49-54. PubMed ID: 12827718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A simulation approach for estimating the loss of womanyears due to cervical cancer and probability of developing cervical cancer.
    Sreenivas V; Prabhakar AK; Ravi R; Luthra UK
    Neoplasma; 1989; 36(5):623-7. PubMed ID: 2812156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
    Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
    J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cost effectiveness analysis of screening strategies for cervical cancer in Tunisia].
    Lazaar HB; Aounallah-Skhiri H; Oueslati F; Frikha H; Achour N; Hsairi M
    East Mediterr Health J; 2010 Jun; 16(6):602-8. PubMed ID: 20799586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cervical cancer screening in Serbia.
    Kesić V; Jovićević-Bekić A; Vujnović M
    Coll Antropol; 2007 Apr; 31 Suppl 2():31-6. PubMed ID: 17598502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cervical cytology screening in Calcutta and adjoining areas with special reference to carcinoma of the uterine cervix.
    Roy A; Dutta K; Majumdar J; Basu S; De S; De N; Chowdhury JR
    Indian J Public Health; 1990; 34(2):98-106. PubMed ID: 2102897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
    Nygård M; Daltveit AK; Thoresen SO; Nygård JF
    BMC Health Serv Res; 2007 Jan; 7():10. PubMed ID: 17244348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knowledge and awareness of cervical cancer and screening among Malaysian women who have never had a Pap smear: a qualitative study.
    Wong LP; Wong YL; Low WY; Khoo EM; Shuib R
    Singapore Med J; 2009 Jan; 50(1):49-53. PubMed ID: 19224084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Women's attitudes to and awareness of smear testing and cervical cancer.
    Yu CK; Rymer J
    Br J Fam Plann; 1998 Jan; 23(4):127-33. PubMed ID: 9882766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cervical cancer screening in a rural population of Zimbabwe.
    Thistle PJ; Chirenje ZM
    Cent Afr J Med; 1997 Sep; 43(9):246-51. PubMed ID: 9509642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experience in screening for cervical cancer in rural areas of Barsi Tehsil (Maharashtra).
    Nene BM; Jayant K; Malvi SG; Dale PS; Deshpande R
    Indian J Cancer; 1994 Mar; 31(1):34-40. PubMed ID: 8063335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sentinel Pap smears in 261 invasive cervical cancer patients in Italy.
    Igidbashian S; Maggioni A; Casadio C; Boveri S; Cristoforoni P; Sideri M
    Vaccine; 2009 May; 27 Suppl 1():A34-8. PubMed ID: 19480959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age at marriage and cervical cancer incidence.
    Prabhakar AK; Menon GR
    Indian J Cancer; 1995 Jun; 32(2):63-8. PubMed ID: 9136459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case-control study of the protective benefit of cervical screening against invasive cervical cancer in NSW women.
    Yang B; Morrell S; Zuo Y; Roder D; Tracey E; Jelfs P
    Cancer Causes Control; 2008 Aug; 19(6):569-76. PubMed ID: 18286380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Mass screening for cervical cancer. Experiences after 25 years of voluntary screening and 2 years of organized screening].
    Thoresen SO; Skare GB; Sandvin O
    Tidsskr Nor Laegeforen; 1997 Aug; 117(18):2613-5. PubMed ID: 9324815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
    Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
    J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of screening for uterine cervix cancer: from theory to practice (author's transl)].
    Riotton G
    Bull Cancer; 1979; 66(4):404-6. PubMed ID: 526628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cervical cancer in Indian rural women: trends over two decades.
    Chhabra S; Bhavani M; Mahajan N; Bawaskar R
    J Obstet Gynaecol; 2010; 30(7):725-8. PubMed ID: 20925620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cancer of the cervix uteri: analysis of the cost-benefit and efficacy of opportunistic screening versus organized screening].
    Castronovo V; Foidart JM; Boniver J
    Rev Med Liege; 1998 May; 53(5):305-7. PubMed ID: 9689888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Epidemiology of cervical cancer (author's transl)].
    Berndt H; Neuser D
    Arch Geschwulstforsch; 1978; 48(3):250-75. PubMed ID: 356802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.